[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

JPH03279313A - External preparation of skin - Google Patents

External preparation of skin

Info

Publication number
JPH03279313A
JPH03279313A JP7965290A JP7965290A JPH03279313A JP H03279313 A JPH03279313 A JP H03279313A JP 7965290 A JP7965290 A JP 7965290A JP 7965290 A JP7965290 A JP 7965290A JP H03279313 A JPH03279313 A JP H03279313A
Authority
JP
Japan
Prior art keywords
external preparation
tranexamic acid
skin
present
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP7965290A
Other languages
Japanese (ja)
Other versions
JP2906269B2 (en
Inventor
Kanemoto Kitamura
謙始 北村
Ataru Iwamoto
岩本 中
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shiseido Co Ltd
Original Assignee
Shiseido Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shiseido Co Ltd filed Critical Shiseido Co Ltd
Priority to JP7965290A priority Critical patent/JP2906269B2/en
Publication of JPH03279313A publication Critical patent/JPH03279313A/en
Application granted granted Critical
Publication of JP2906269B2 publication Critical patent/JP2906269B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Cosmetics (AREA)

Abstract

PURPOSE:To obtain an external preparation of skin having increased stability to discoloration, excellent beautifying effects and high safety, by blending sodium hydrogensulfite with a tranexamic acid. CONSTITUTION:(A) Sodium hydrogensulfite is blended with (B) a tranexamic acid (trans-4-aminomethylcylohexane-1-carboxylic acid) or a salt thereof (e.g. Mg salt, K salt or sulfate) or a derivative thereof (e.g. vitamin ester or phenyl ester) or a mixture thereof. The amount of the component A blended is 0.0001-1 pt.wt., preferably 0.001-1 pt.wt. based on 1 pt.wt. component B and the amount of the component B blended is 0.1-30wt.%, preferably 1-20wt.% based on total amounts of the external preparation.

Description

【発明の詳細な説明】 〔産業上の利用分野〕 本発明は、トラネキサム酸もしくはその塩類、もしくは
その誘導体またはこれらの混合物を配合してなる皮膚外
用剤の着色に対する安定性を増し、さらに美白効果に優
れ、安全性の高い皮膚外用剤に関するものである。
Detailed Description of the Invention [Industrial Application Field] The present invention improves the stability against coloring of external skin preparations containing tranexamic acid, salts thereof, derivatives thereof, or mixtures thereof, and further improves the whitening effect. The present invention relates to a topical skin preparation that has excellent properties and is highly safe.

〔従来の技術〕[Conventional technology]

トラネキサム酸は化学名をトランス−4−アミノメチル
シクロヘキサン−1−カルボン酸と言い、皮膚のじみや
そばかすなどの原因となるメラニン色素の生成に関与す
るメラノサイトの活性化因子を抑制する作用を有するの
で美白効果を有する。この作用を利用してトラネキサム
酸やその誘導体を有効成分とした皮膚外用剤の特許が開
示されている。(特開平1−93519号公報、特開平
1−186811号公報等) 〔発明が解決しようとする課題〕 従来技術の問題点 ところが、トラネキサム酸、その塩類、その誘導体は製
剤の基材に配合し、日光暴露条件下や高温下に保存する
と、着色しはじめ、その着色度は経時的に増大し褐変化
する傾向がある。この着色によって商品価値が低下する
ことは避けられない発明の目的 本発明者らはトラネキサム酸、その塩類、その誘導体の
着色が経時的に増大するのを防止する目的で、さまざま
な有機酸、例えばクエン酸、酒石酸、亜硫酸水素ナトリ
ウム、亜硫酸アンモニウム、亜硫酸カリウム、亜硫酸ナ
トリウム、或いは亜硫酸カルシウム等について種々検討
した結果、亜硫酸水素ナトリウムに優れた着色防止効果
があることを見出し、特に亜硫酸水素ナトリウムPH4
〜7の弱酸性から中性領域で使用することによって著し
く着色が防止されることを見出し、本発明を完成するに
至った。
The chemical name of tranexamic acid is trans-4-aminomethylcyclohexane-1-carboxylic acid, and it has the effect of suppressing melanocyte activation factors that are involved in the production of melanin pigment, which causes skin blemishes and freckles. Has a whitening effect. Utilizing this effect, patents have been disclosed for external preparations for skin containing tranexamic acid or its derivatives as active ingredients. (JP-A No. 1-93519, JP-A No. 1-186811, etc.) [Problems to be solved by the invention] Problems of the prior art However, tranexamic acid, its salts, and its derivatives cannot be blended into the base material of the preparation. When stored under conditions of exposure to sunlight or at high temperatures, it begins to become colored, and the degree of coloration tends to increase over time and turn brown. It is inevitable that this coloring will reduce the commercial value.Purpose of the InventionThe present inventors have developed various organic acids, e.g. As a result of various studies on citric acid, tartaric acid, sodium hydrogen sulfite, ammonium sulfite, potassium sulfite, sodium sulfite, calcium sulfite, etc., we found that sodium hydrogen sulfite has an excellent coloring prevention effect, and in particular, sodium hydrogen sulfite PH4
It has been found that coloring can be significantly prevented by using it in the weakly acidic to neutral range of 7 to 7, and the present invention has been completed.

〔課題を解決するための手段〕[Means to solve the problem]

すなわち、本発明は、亜硫酸水素ナトリウムとトラネキ
サム酸もしくはその塩類もしくはその誘導体またはこれ
らの混合物を配合することを特徴とする皮膚外用剤であ
る。
That is, the present invention is an external skin preparation characterized by blending sodium bisulfite with tranexamic acid, a salt thereof, a derivative thereof, or a mixture thereof.

以下、本発明の構成について詳述する。Hereinafter, the configuration of the present invention will be explained in detail.

本発明で用いられるトラネキサム酸およびその塩および
その誘導体は抗プラスミン剤として一般に用いられてお
り、化粧品用途では、安全性が高いことを特徴とする成
分として知られている。
Tranexamic acid, its salts, and its derivatives used in the present invention are generally used as antiplasmin agents, and are known as components characterized by high safety in cosmetic applications.

(特願昭42−36980)またその製造法は特許第2
40611号、特許第242664号、特許第4804
11号、特許第488168号等によって知られている
。トラネキサム酸は融点262〜267°C1白色の結
晶または粉末で臭いはなく、味は苦い。トラネキサム酸
の塩は通常使用される塩として、Mg、Ca5K等の金
属塩類、硫酸塩等があり、誘導体としてはビタミンA酸
エステル、ビタミンAエステル、ビタミンEエステル、
ビタミンCエステル、ビタミンDエステル等のビタミン
エステル類、フェニルエステル類、N、N−マレオイル
ミノトラネキサム酸等が挙げられるが、これらに限定さ
れるものではない。
(Patent application 1973-36980) Also, the manufacturing method is patented in the second patent.
No. 40611, Patent No. 242664, Patent No. 4804
No. 11, Japanese Patent No. 488168, etc. Tranexamic acid is a white crystal or powder with a melting point of 262-267° C1, no odor, and a bitter taste. Commonly used salts of tranexamic acid include metal salts such as Mg and Ca5K, sulfates, etc., and derivatives include vitamin A acid ester, vitamin A ester, vitamin E ester,
Examples include, but are not limited to, vitamin esters such as vitamin C ester and vitamin D ester, phenyl esters, N,N-maleoylminotranexamic acid, and the like.

本発明に係わる皮膚外用剤に配合される亜硫酸水素ナト
リウムの配合量はトラネキサム酸もしくはその塩類もし
くはその誘導体、またはこれらの混合物1重量部に対し
てo、oooi〜1重量部、好ましくは0.001〜0
.1重量部である。
The amount of sodium bisulfite to be blended in the skin external preparation according to the present invention is from o, oooi to 1 part by weight, preferably 0.001 part by weight, per 1 part by weight of tranexamic acid, its salts, or its derivatives, or a mixture thereof. ~0
.. It is 1 part by weight.

また本発明に用いられるトラネキサム酸及びその塩類も
しくはその誘導体、またはこれらの混合物の皮膚外用剤
全量に対する配合量は通常0.1〜30重量%であり、
好ましくは1〜20重量%である。
Further, the amount of tranexamic acid, salts thereof, derivatives thereof, or mixtures thereof used in the present invention, based on the total amount of the skin external preparation, is usually 0.1 to 30% by weight,
Preferably it is 1 to 20% by weight.

本発明の皮膚外用剤においては前記必須構成成分の他に
、化粧品、医薬品等に一般に用いられる各種成分、すな
わち水性成分、粉末成分、界面活性剤、保湿剤、増粘剤
、紫外線吸収剤、色剤、香料、さらには酢酸トコフェロ
ール、バントテニルエチルエーテル、グリチルリチン酸
塩等の皮膚栄養剤等を本発明の効果を損なわない範囲で
使用することができる。
In addition to the above-mentioned essential components, the external skin preparation of the present invention contains various components commonly used in cosmetics, pharmaceuticals, etc., namely, an aqueous component, a powder component, a surfactant, a humectant, a thickener, an ultraviolet absorber, and a color. Agents, fragrances, skin nutrients such as tocopherol acetate, bantothenyl ethyl ether, glycyrrhizinate, etc. can be used within the range that does not impair the effects of the present invention.

本発明の皮膚外用剤の剤型は任意であり、例えば化粧水
等の可溶化系、乳液、クリーム等の乳化系あるいは軟膏
、 分散液等の剤型をとることかき る。
The formulation for external use on the skin of the present invention may be in any form, such as a solubilized system such as a lotion, an emulsified system such as a milky lotion or a cream, or an ointment or a dispersion.

〔発明の効果〕〔Effect of the invention〕

本発明の皮膚外用剤は美白効果を有するトラネキサム酸
及びその塩類及びその誘導体の経時での着色を防止する
効果に優れた皮膚外用剤である。
The external skin preparation of the present invention is an excellent skin preparation for preventing discoloration of tranexamic acid, its salts, and its derivatives over time, which have whitening effects.

〔実施例〕〔Example〕

次に実施例を挙げて本発明を詳述する。 Next, the present invention will be explained in detail with reference to Examples.

本発明はこれによって限定されるものではない。The present invention is not limited thereby.

着色防止効果試験 下記に示した実施例1の美容液の処方で亜硫酸水素ナト
リウムの添加量をA(0%)、B(0゜01%)、C(
0,03%)とし、これら試料を60°Cの恒温槽に1
か月間放置した後3Mカラーコンピューター(モデル 
5M−4)(スガ試験機株式会社)を使用してΔEを測
定した。尚、基準値は試作当日に測定した数値を用いた
。その結果を表−1に示す。
Coloration prevention effect test In the serum formulation of Example 1 shown below, the amount of sodium bisulfite added was A (0%), B (0°01%), C (
0.03%), and these samples were placed in a constant temperature bath at 60°C.
After leaving it for a month, the 3M color computer (model
5M-4) (Suga Test Instruments Co., Ltd.) to measure ΔE. Note that the reference value used was the value measured on the day of trial production. The results are shown in Table-1.

実施例1    美容液      重量%(A) 95%エタノール         10.0ポリオキ
シエチレン(20)     1.0オレイルエーテル パントテニルエチルエーテル    0. 1メチルパ
ラベン         0.15(B) 水酸化カリウム          0. 1(C) グリセリン           5.0ジプロピレン
グリコール     10.0亜硫酸水素ナトリウム 
     0.03トラネキサム酸         
 7.0カルボキシビニルポリマー     0.2精
製水              残余く製法〉 A、Cをそれぞれ均一に溶解し、CにAを加えて可溶化
する。対でBを加え本発明の美容液を得た。
Example 1 Beauty serum Weight % (A) 95% ethanol 10.0 Polyoxyethylene (20) 1.0 Oleyl ether pantothenyl ethyl ether 0. 1 Methylparaben 0.15 (B) Potassium hydroxide 0. 1(C) Glycerin 5.0 Dipropylene glycol 10.0 Sodium bisulfite
0.03 tranexamic acid
7.0 Carboxyvinyl polymer 0.2 Purified water Production method> Dissolve A and C uniformly, and add A to C to solubilize. B was added in pairs to obtain the serum of the present invention.

表−1 表−1から判るように、本発明の美容液は着色すること
もなく、安定性にきわめて優れていた。
Table 1 As can be seen from Table 1, the serum of the present invention was not colored and had excellent stability.

実施例2    クリーム (A) セタノール マイクロクリスタリンワックス ワセリン スクワラン イソオクタン酸セチル 重量% ホホバ油              2.0ポリオキ
シエチレン(20)      2.0ソルビタンモノ
ラウリン酸エステル 酢酸トコフエロール        0.05バントテ
ニルエチルエーテル     0. 1香料     
           0.3エチルパラベン    
       0.3(B) トラネキサム酸のに塩        5. 0亜硫酸
水素ナトリウム       0.011.3−ブチレ
ングリコール     5. 0プロピレングリコール
        5. 0グリチルリチン酸     
    0.05モノアンモニウム塩 精製水               残余油相部Aを
70°Cにて溶解する。水相部Bを70°Cにて溶解し
、BにAを混合し、乳化機で乳化後、乳化物を熱交換器
で30’Cまで冷却して本発明のクリームを得た。
Example 2 Cream (A) Setanol Microcrystalline wax Petrolatum Squalane Cetyl isooctanoate Weight % Jojoba oil 2.0 Polyoxyethylene (20) 2.0 Sorbitan monolaurate Tocopherol acetate 0.05 Bantothenyl ethyl ether 0. 1 fragrance
0.3 ethylparaben
0.3(B) Tranexamic acid salt 5. 0 Sodium bisulfite 0.011.3-Butylene glycol 5. 0 propylene glycol 5. 0 glycyrrhizic acid
0.05 monoammonium salt purified water Dissolve the remaining oil phase A at 70°C. Aqueous phase part B was dissolved at 70°C, A was mixed with B, and after emulsifying with an emulsifier, the emulsion was cooled to 30'C with a heat exchanger to obtain the cream of the present invention.

実施例3  乳液 (A) ステアリン酸 ピースワックス ワセリン 脱臭ラノリン 月見草油 ミリスチン酸イソプロピル ポリオキシエチレン(60) 硬化ヒマシ油 酢酸トコフェロール エチルパラベン ブチルパラベン 香料 (B) トラネキサム酸のNa塩 亜硫酸水素ナトリウム グリセリン ヒアルロン酸ナトリウム カルボキシビニルポリマー 重量% 10゜ 水酸化カリウム          0.2精製水  
            残余油相部Aを70°Cにて
溶解する。水相部Bを70°Cにて溶解し、BにAを混
合し、乳化機で乳化後、乳化物を熱交換器で30°Cま
で冷却して本発明の乳液を得た。
Example 3 Emulsion (A) Stearic acid peace wax Vaseline Deodorized lanolin Evening primrose oil Isopropyl myristate Polyoxyethylene (60) Hydrogenated castor oil Tocopherol acetate Ethyl paraben Butyl paraben Fragrance (B) Sodium salt of tranexamic acid Sodium bisulfite Glycerin Sodium hyaluronate Carboxyvinyl polymer weight% 10° Potassium hydroxide 0.2 Purified water
The remaining oil phase A is dissolved at 70°C. Aqueous phase part B was dissolved at 70°C, A was mixed with B, and after emulsifying with an emulsifier, the emulsion was cooled to 30°C with a heat exchanger to obtain an emulsion of the present invention.

実施例4    パック トラネキサム酸 亜硫酸水素ナトリウム ポリビニルアルコール (ケン化度90、重合度2000) 95%エチルアルコール グリセリン オリーブ油 酢酸トコフェロール エチルパラベン 香料 精製水 重量% 3.0 0.3 13.0 7、O 1Ol 0 3、 0 0.2 0.2 0.2 残余 く製法〉 各成分を80°Cで加熱混合して本発明のパックを得た
Example 4 Packed tranexamic acid sodium bisulfite Polyvinyl alcohol (saponification degree 90, polymerization degree 2000) 95% ethyl alcohol Glycerin Olive oil Tocopherol acetate Ethyl paraben Fragrance Purified water Weight % 3.0 0.3 13.0 7, O 1Ol 0 3. 0 0.2 0.2 0.2 Production method> Each component was heated and mixed at 80°C to obtain a pack of the present invention.

実施例5    二層化粧水    重量%トラネキサ
ム酸          1. 0亜硫酸水素ナトリウ
ム     o、ooi95%エタノール      
   10.0ポリオキシエチレン(20)−2− オクチルドデシルエーテル    1. 0クエン酸 
            0.01クエン酸ソーダ  
        0.09カオリン         
     0. 2ベンガラ            
   0. 5グリチルリチン酸        0.
05モノアンモニウム塩 メチルパラベン          0. 2香料  
             0. 1精製水     
         残余く製法〉 実施例 1に準じる。
Example 5 Two-layer lotion Weight % tranexamic acid 1. 0 Sodium bisulfite o, ooi95% ethanol
10.0 Polyoxyethylene (20)-2-octyldodecyl ether 1. 0 citric acid
0.01 Sodium citrate
0.09 kaolin
0. 2 Bengala
0. 5 Glycyrrhizic acid 0.
05 Monoammonium salt methylparaben 0. 2 fragrance
0. 1 purified water
Remaining manufacturing method> Same as Example 1.

実施例2〜5はいずれも60°Cの恒温槽に1か月間放
置した後も着色することなく、安定性にきわめて優れ、
美白効果に優れていた。
Examples 2 to 5 all showed excellent stability without coloring even after being left in a constant temperature bath at 60°C for one month.
It had an excellent whitening effect.

Claims (3)

【特許請求の範囲】[Claims] (1)亜硫酸水素ナトリウムとトラネキサム酸もしくは
その塩類、もしくはその誘導体、またはこれらの混合物
を配合することを特徴とする皮膚外用剤。
(1) A skin external preparation characterized by containing sodium bisulfite and tranexamic acid or its salts, or a derivative thereof, or a mixture thereof.
(2)皮膚外用剤中の亜硫酸水素ナトリウムの含量がト
ラネキサム酸もしくはその塩類、もしくはその誘導体ま
たはこれらの混合物1重量部に対して0.0001〜1
重量部である請求項1記載の皮膚外用剤。
(2) The content of sodium bisulfite in the skin external preparation is 0.0001 to 1 part by weight of tranexamic acid or its salts, or its derivatives, or a mixture thereof.
The skin external preparation according to claim 1, which is in parts by weight.
(3)皮膚外用剤中の亜硫酸水素ナトリウムの含量がト
ラネキサム酸もしくはその塩類、もしくはその誘導体ま
たはこれらの混合物1重量部に対して0.001〜1重
量部である請求項1記載の皮膚外用剤。
(3) The skin external preparation according to claim 1, wherein the content of sodium bisulfite in the skin external preparation is 0.001 to 1 part by weight per 1 part by weight of tranexamic acid, its salts, its derivatives, or mixtures thereof. .
JP7965290A 1990-03-28 1990-03-28 External preparation for skin Expired - Lifetime JP2906269B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP7965290A JP2906269B2 (en) 1990-03-28 1990-03-28 External preparation for skin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7965290A JP2906269B2 (en) 1990-03-28 1990-03-28 External preparation for skin

Publications (2)

Publication Number Publication Date
JPH03279313A true JPH03279313A (en) 1991-12-10
JP2906269B2 JP2906269B2 (en) 1999-06-14

Family

ID=13696062

Family Applications (1)

Application Number Title Priority Date Filing Date
JP7965290A Expired - Lifetime JP2906269B2 (en) 1990-03-28 1990-03-28 External preparation for skin

Country Status (1)

Country Link
JP (1) JP2906269B2 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5989596A (en) * 1997-06-09 1999-11-23 Coletica Compositions comprising a depigmenting agent consisting of sulfites and metabisulfites and plant extracts for use in inhibiting melanogenesis or for depigmenting
WO2010016509A1 (en) * 2008-08-06 2010-02-11 第一三共ヘルスケア株式会社 Stable pharmaceutical composition containing tranexamic acid and ascorbic acid
JP2014062077A (en) * 2012-09-24 2014-04-10 Kyoei Kagaku Kogyo Kk Cosmetic composition
JP2016515572A (en) * 2013-04-04 2016-05-30 ヒュンダイ ファーム カンパニー リミテッド External preparation composition with improved skin permeation
JP2019202963A (en) * 2018-05-24 2019-11-28 日本精化株式会社 Tranexamic acid-containing cosmetic or skin external preparation

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5989596A (en) * 1997-06-09 1999-11-23 Coletica Compositions comprising a depigmenting agent consisting of sulfites and metabisulfites and plant extracts for use in inhibiting melanogenesis or for depigmenting
WO2010016509A1 (en) * 2008-08-06 2010-02-11 第一三共ヘルスケア株式会社 Stable pharmaceutical composition containing tranexamic acid and ascorbic acid
JP5517938B2 (en) * 2008-08-06 2014-06-11 第一三共ヘルスケア株式会社 Stable tranexamic acid and ascorbic acid-containing pharmaceutical composition
JP2014062077A (en) * 2012-09-24 2014-04-10 Kyoei Kagaku Kogyo Kk Cosmetic composition
JP2016515572A (en) * 2013-04-04 2016-05-30 ヒュンダイ ファーム カンパニー リミテッド External preparation composition with improved skin permeation
JP2018115181A (en) * 2013-04-04 2018-07-26 ヒュンダイ ファーム カンパニー リミテッド Composition for external use preparation with improved skin permeability
US10292955B2 (en) 2013-04-04 2019-05-21 Hyundai Pharm Co., Ltd. Composition for external use preparation with improved transdermal permeability
JP2019202963A (en) * 2018-05-24 2019-11-28 日本精化株式会社 Tranexamic acid-containing cosmetic or skin external preparation

Also Published As

Publication number Publication date
JP2906269B2 (en) 1999-06-14

Similar Documents

Publication Publication Date Title
EP0440398B1 (en) Skin care compositions
KR930007911B1 (en) External preparations free of discoloration
US4925666A (en) Solubilized benzoyl peroxide and cosmetic solution including solubilized benzoyl peroxide
JPH083034A (en) Combination of active compounds with content of glycerol alkyl ethers, and cosmetics and skin science compound containing combination of said active compound
JPS5883648A (en) Lanolin acid copper and local composition
JP2003504319A (en) Self-tanning composition containing DHA and propolis extract
JPS62108804A (en) Cosmetic
JPH04124122A (en) Blackening agent of preventing gray hair
JPS61215318A (en) External agent for skin
JPH0545569B2 (en)
JPH07101844A (en) Multilayered emulsion
JPH03279313A (en) External preparation of skin
JPH0616532A (en) Whitening and beautifying agent
JPS6256411A (en) Beautifying agent
JPS61215311A (en) External agent for skin
JP4053966B2 (en) Skin external preparation and skin irritation relieving agent
JPS63174910A (en) External drug for skin
JPS62129212A (en) Cosmetic
JPH10279421A (en) Preparation for external use for skin
JPH01100113A (en) External preparation for skin
JP5670008B2 (en) Adapalene-containing external preparation composition
JPH07196466A (en) Cosmetic composition formulated with tea powder
JPH0692833A (en) Skin external agent
JP2906270B2 (en) External preparation for skin
JPH07112966B2 (en) Skin cosmetics

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080402

Year of fee payment: 9

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090402

Year of fee payment: 10

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100402

Year of fee payment: 11

EXPY Cancellation because of completion of term